406 related articles for article (PubMed ID: 25562189)
1. A role for the BDNF gene Val66Met polymorphism in schizophrenia? A comprehensive review.
Notaras M; Hill R; van den Buuse M
Neurosci Biobehav Rev; 2015 Apr; 51():15-30. PubMed ID: 25562189
[TBL] [Abstract][Full Text] [Related]
2. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
[TBL] [Abstract][Full Text] [Related]
3. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
[TBL] [Abstract][Full Text] [Related]
4. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T
Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563
[TBL] [Abstract][Full Text] [Related]
5. Association of the brain-derived neurotrophic factor Val66Met polymorphism with negative symptoms severity, but not cognitive function, in first-episode schizophrenia spectrum disorders.
Mezquida G; Penadés R; Cabrera B; Savulich G; Lobo A; González-Pinto A; Penzol MJ; Corripio I; Fernandez-Egea E; Gassó P; Cuesta MJ; Bernardo M;
Eur Psychiatry; 2016 Oct; 38():61-69. PubMed ID: 27668551
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder.
Kanazawa T; Glatt SJ; Kia-Keating B; Yoneda H; Tsuang MT
Psychiatr Genet; 2007 Jun; 17(3):165-70. PubMed ID: 17417060
[TBL] [Abstract][Full Text] [Related]
7. No association between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and schizophrenia in Asian populations: Evidence from a case-control study and meta-analysis.
Naoe Y; Shinkai T; Hori H; Fukunaka Y; Utsunomiya K; Sakata S; Matsumoto C; Shimizu K; Hwang R; Ohmori O; Nakamura J
Neurosci Lett; 2007 Mar; 415(2):108-12. PubMed ID: 17267117
[TBL] [Abstract][Full Text] [Related]
8. Interaction between catechol-O-methyltransferase (COMT) Val108/158Met and brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in age at onset and clinical symptoms in schizophrenia.
Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aki H; Sumitani S; Itakura M; Ohmori T
J Neural Transm (Vienna); 2007 Feb; 114(2):255-9. PubMed ID: 16897602
[TBL] [Abstract][Full Text] [Related]
9. BDNF-Val66Met-polymorphism impact on cortical plasticity in schizophrenia patients: a proof-of-concept study.
Strube W; Nitsche MA; Wobrock T; Bunse T; Rein B; Herrmann M; Schmitt A; Nieratschker V; Witt SH; Rietschel M; Falkai P; Hasan A
Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25612896
[TBL] [Abstract][Full Text] [Related]
10. BDNF Val66Met Genotype Interacts With a History of Simulated Stress Exposure to Regulate Sensorimotor Gating and Startle Reactivity.
Notaras MJ; Hill RA; Gogos JA; van den Buuse M
Schizophr Bull; 2017 May; 43(3):665-672. PubMed ID: 27262112
[TBL] [Abstract][Full Text] [Related]
11. Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.
Hashim HM; Fawzy N; Fawzi MM; Karam RA
J Psychiatr Res; 2012 Jun; 46(6):762-6. PubMed ID: 22521161
[TBL] [Abstract][Full Text] [Related]
12. Val66Met functional polymorphism and serum protein level of brain-derived neurotrophic factor (BDNF) in acute episode of schizophrenia and depression.
Skibinska M; Groszewska A; Kapelski P; Rajewska-Rager A; Pawlak J; Dmitrzak-Weglarz M; Szczepankiewicz A; Twarowska-Hauser J
Pharmacol Rep; 2018 Feb; 70(1):55-59. PubMed ID: 29331787
[TBL] [Abstract][Full Text] [Related]
13. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
[TBL] [Abstract][Full Text] [Related]
14. The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy.
Notaras M; Hill R; van den Buuse M
Mol Psychiatry; 2015 Aug; 20(8):916-30. PubMed ID: 25824305
[TBL] [Abstract][Full Text] [Related]
15. The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese patients with bipolar disorder and schizophrenia.
Chen SL; Lee SY; Chang YH; Chen SH; Chu CH; Wang TY; Chen PS; Lee IH; Yang YK; Hong JS; Lu RB
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():99-104. PubMed ID: 24468644
[TBL] [Abstract][Full Text] [Related]
16. BDNF Val66Met polymorphism and hippocampal volume in neuropsychiatric disorders: A systematic review and meta-analysis.
Harrisberger F; Smieskova R; Schmidt A; Lenz C; Walter A; Wittfeld K; Grabe HJ; Lang UE; Fusar-Poli P; Borgwardt S
Neurosci Biobehav Rev; 2015 Aug; 55():107-18. PubMed ID: 25956254
[TBL] [Abstract][Full Text] [Related]
17. Brain-Derived Neurotrophic Factor Val66Met Human Polymorphism Impairs the Beneficial Exercise-Induced Neurobiological Changes in Mice.
Ieraci A; Madaio AI; Mallei A; Lee FS; Popoli M
Neuropsychopharmacology; 2016 Dec; 41(13):3070-3079. PubMed ID: 27388329
[TBL] [Abstract][Full Text] [Related]
18. Brain-derived neurotrophic factor (BDNF) and neurocognitive deficits in people with schizophrenia: a meta-analysis.
Ahmed AO; Mantini AM; Fridberg DJ; Buckley PF
Psychiatry Res; 2015 Mar; 226(1):1-13. PubMed ID: 25681004
[TBL] [Abstract][Full Text] [Related]
19. BDNF val66met polymorphism is associated with age at onset and intensity of symptoms of paranoid schizophrenia in a Polish population.
Suchanek R; Owczarek A; Paul-Samojedny M; Kowalczyk M; Kucia K; Kowalski J
J Neuropsychiatry Clin Neurosci; 2013; 25(1):88-94. PubMed ID: 23487199
[TBL] [Abstract][Full Text] [Related]
20. Generation of three induced pluripotent stem cell lines carrying different variants of the BDNF (Val66Met) polymorphism.
Horschitz S; Frank J; Koch P
Stem Cell Res; 2023 Feb; 66():102989. PubMed ID: 36473250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
